Filgrastim biosimilar (Biocon)

非格司亭生物类似药（Biocon）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Biocon)
Drug Alias NameRecombinant human granulocyte macrophage colony stimulating factor (Biocon)重组人粒细胞刺激因子（Biocon）非格司亭生物仿制药（Biocon）Nufil
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2008/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiocon Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A